Home World News EMA Recommends Extension of Indications for Dostarlimab World News EMA Recommends Extension of Indications for Dostarlimab By Ogkologos - January 23, 2025 736 0 Facebook Twitter Google+ Pinterest WhatsApp Change concerns the first-line treatment of patients with endometrial cancer Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk... March 30, 2026 Patient Guide in Testicular Cancer Now Available Also in German January 14, 2026 The Investigational PD1 Antibody, Tislelizumab, Shows Promise in Patients With Unresectable... July 1, 2021 Cancer in My Community: Improving Access to Palliative Care in Indonesia January 13, 2022 Load more HOT NEWS ESMO Breast Cancer Congress 2023 A Pet Pug Helped Two Sisters Realize They Both Had Breast... Breast Cancer Risk Genes Opinion: ‘The idea that a tobacco company might profit off my...
